logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

More controversy over proposed streamlining of statutory guidance on child protection

30 July 2012

Two more organisations have expressed concern about the effect of the proposed changes to Safeguarding Statutory Guidance.

Their particular concern appears to be that local authorities with limited resources might allow long delays in investigating referrals thereby leaving children at risk in dangerous situations for longer. They are also concerned that Children in Need, such as the disabled, homeless and trafficked children may have their needs unaddressed for much longer.

When these reforms come in, as they inevitably will, it will be essential that each local authority:-

  • sets out what its own guidelines are
  • gives all staff members thorough training in them
  • makes sure the resources are there
If not, both claims and challenges will inevitably follow. They will not be defensible unless councils can evidence proper policy and training procedures. The statutory consultation closes on 4th September.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up